Cargando…
Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
BACKGROUND: Regulatory approval of novel therapies by the FDA does not guarantee insurance coverage requisite for most clinical use. In the United States, the largest health insurance payer is the Centers for Medicare & Medicaid Services (CMS), which provides Part D prescription drug benefits to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397592/ https://www.ncbi.nlm.nih.gov/pubmed/30479199 http://dx.doi.org/10.18553/jmcp.2018.24.12.1230 |